All Posts > Content under Pharma/Biotech
The Crimea Vote And Doubling Down In China Gas Search
Article By:
Vivian Lewis
Read
Wednesday, March 19, 2014 2:35 PM EDT
To pay for the overnight Hong Kong incorporated Chinese oilfield services company, in which Schlumberger Ltd owns 20%, I halved my holdings in Yandex, the Black Sea internet services provider, and in Singapore-based Indian REIT Ascendas India Trust. Plus more from Africa, Britain, Cuba, Finland, The Netherlands, Spain, Belgium, Canada, and Israel.
In this article: AGU, CBI, GSK, NVS, SLB, TEF, VOD, VZ, ACNDF, ATONY, PSGTY, SAXPF, CHSCP, RBOS.HW, TEVA, YNDX, CUBA, AROFF, RNA, GLPG
On China And Small Caps
Article By:
Vivian Lewis
Read
Monday, March 17, 2014 2:18 PM EDT
As the world awaits the outcome of the stand-off in Crimea, I thought it might be useful to look at the huge country on other side of the globe, China.
In this article: BLX, COV, GSK, JPM, NOK, RDY, WX, HKMPY, NPSNY, PPEHF, TCTZF, CSIQ, ILMN, MSFT, TEVA, YNDX, RMB
Weekly Investment Report: Stocks To Watch
Article By:
E.B. Capital Markets
Read
Monday, March 17, 2014 2:02 PM EDT
Our weekly best and worst reports show you stocks with the best potential returns over the coming 6 to 12 months.
In this article: AGN, AMP, AON, AZO, BDC, BDX, BWA, CLB, CNO, DDS, HAS, HRL, ITT, JPM, LNC, LO, TFX, AGYS, CDNS, DIOD, LFUS, MYL, SIAL, SNHY
Narcotics And Other Drug Related Stocks Around The Globe
Article By:
Vivian Lewis
Read
Saturday, March 15, 2014 4:00 PM EDT
A scandal in Africa,Tullow Oil plc (TLW), a British oil exploration firm,re, has suspended work at a Guinea offshore oil site because its US partner is under investigation by the SEC for alleged bribery. Plus the latest updates on the global pharmaceutical industry
In this article: BNS, CCJ, GSK, NOK, PFE, RDY, VALE, FAX, FCO, DGRLY, GLPYY, HKMPY, OROCF, TEVA, MNK
Small Cap Report - Best And Worst
Article By:
E.B. Capital Markets
Read
Thursday, March 13, 2014 7:43 PM EDT
Our weekly best and worst reports show you stocks with the best potential returns over the coming 6 to 12 months.
In this article: CDE, CHE, GBX, GOL, GTS, HXM, HZO, RSH, STRI, AFFY, PENX, REDF, SNTA, SPPI, VASC, AGYS, BLDR, CFNL, DIOD, ELNK, FINL, LYTS, SNHY, SRDX, UNTD, WIRE, EBIX
Drugs From Israel, Jordan, And Britain, One Safer Than The Little Blue Pill
Article By:
Vivian Lewis
Read
Thursday, March 13, 2014 11:15 AM EDT
Until last week, Warren Buffett seemed to be a keen Tesco devotee. I’m not entirely sure what got him so enthused in the first place - nor what’s got him dumping the stock now. Plus updates on some pharmaceutical stocks and more..
Small Cap Report - Best And Worst
Article By:
E.B. Capital Markets
Read
Thursday, March 6, 2014 8:18 PM EDT
Our weekly best and worst reports show you stocks with the best potential returns over the coming 6 to 12 months.
In this article: CDE, CQB, EXAM, GBX, HMY, STRI, AFFY, REDF, SABA, SIGM, VASC, AGYS, BLDR, CWCO, ELNK, FINL, FORM, UNTD, EBIX
Bitcoins And Trading In Tandem With Putin
Article By:
Vivian Lewis
Read
Thursday, March 6, 2014 2:48 PM EDT
Professor Williams summarized the origins of the new money proxy in the wake of the global financial crisis and the rise in risks which resulted.
In this article: MHG.OL, ABX, BNS, DB, EC, RDY, STP, OROCF, PDYPF, BIDU, CSIQ, GOOG, LBTYA, YNDX, BITCOMP
Look At This Stock - SNSS
Article By:
Jeff Pierce
Read
Wednesday, March 5, 2014 5:26 AM EDT
It seem like everyday this stock shows up on my screeners so I'm not going to deny it the moment in the spotlight it deserves any longer. We are definitely in a major bull market in phrama stocks as they always make up a big portion of my scan results.
In this article: SNSS
Dogs Of The Dow: 3.3.14
Article By:
Guy Lerner
Read
Monday, March 3, 2014 8:40 PM EDT
The Dogs of the Dow is a stock picking strategy devoted to selecting the highest dividend paying stocks in the Dow Jones Industrial Average. It is one of the longest running and easiest to implement strategies.
Concerns About The Super Potent New Opiate Painkiller Zohydro
Article By:
Ilene Carrie
Read
Sunday, March 2, 2014 11:00 PM EDT
Zohydro, a new, super potent opiate pain killer, received FDA approval on Oct. 25, 2014, in spite of significant concerns regarding its potential for abuse.
In this article: ZGNX